Summary Box: J & J in talks with device maker

Mon, 04/18/2011 - 11:17am
The Associated Press

IN PLAY: Synthes Inc., a Swiss-U.S. maker of orthopedic implants and instruments, confirms it's in acquisition talks with Johnson & Johnson, a top global manufacturer of medical devices.

J&J RATIONALE: It could raise revenue with Synthes' $4 billion in sales, and cut overlapping jobs to boost profit. Longer-term, it would gain a dominant position in the growing market for orthopedic surgery products, particularly for trauma patients.

SWISS RICHES: The sale could make multibillionaire chairman Dr. Hansjorg Wyss, who owns 40 percent of Synthes, Switzerland's richest man.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.